March 11-13, 2021
To help you get as much value from NASH-TAG 2021 as possible, we have identified several presentations and articles we find most interesting. Our daily podcasts will summarize these and discuss what they suggest for the future of NASH/NAFLD therapies.
Surfers Jörn Schattenberg, Louise Campbell and Roger Green host the Season 3, Year-in-Review episode to reflect on major themes and takeaways from a momentous 2022 in NAFLD.
S3-E57.5 – From the Vault: “Seeing what Should Be” – Imaging the Liver To Assess Functioning Hepatocytes
In this episode From the Vault, Antaros Medical’s Chief Scientific Officer Lars Johansson joins Stephen Harrison, Louise Campbell, and Roger Green to reprise the key points of his 2021 Paris NASH talk. This conversation revolves around the implications of Lars’s comment that we should track and analyze functioning hepatocyte cells as an excellent marker for liver function.
In discussing the Liver Forum, Executive Director Veronica Miller joins guest Manal Abdelmalek, co-host Jörn Schattenberg and Roger Green to investigate how to study efficacy and safety in real time, using collective knowledge and experience with therapies for advancing liver disease. In this final conversation, Veronica, Manal and Jörn each provide their unique perspectives on critical success factors for placebo cohorts.
Executive Director Veronica Miller joins guest Manal Abdelmalek and co-host Jörn Schattenberg (both Steering Committee members) to discuss ongoing activities of the Liver Forum. This conversation explores a priori placebo response rates and challenges in managing samples through trials.
Executive Director Veronica Miller joins guest Manal Abdelmalek and co-host Jörn Schattenberg (both Steering Committee members) to introduce the origins of the Liver Forum. This conversation goes on to explore an ongoing project aimed to develop research tools and metrics that can capture the richness available in a plethora of data emerging from NASH studies.
In this conversation, Executive Director Veronica Miller introduces her path to the Liver Forum. She details her career history in HIV research and the establishment of the HIV Forum before working on HCV and eventually NAFLD.